Bank of Montreal Can grew its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 12.4% in the third quarter, HoldingsChannel reports. The institutional investor owned 415,759 shares of the company’s stock after buying an additional 46,006 shares during the quarter. Bank of Montreal Can’s holdings in Henry Schein were worth $35,352,000 at the end of the most recent reporting period.
Other large investors have also made changes to their positions in the company. McAdam LLC acquired a new stake in shares of Henry Schein in the third quarter valued at $104,000. NEXT Financial Group Inc acquired a new stake in shares of Henry Schein in the third quarter valued at $103,000. Squar Milner Financial Services LLC acquired a new stake in shares of Henry Schein in the second quarter valued at $120,000. Piedmont Investment Advisors LLC acquired a new stake in shares of Henry Schein in the second quarter valued at $130,000. Finally, Fuller & Thaler Asset Management Inc. increased its stake in shares of Henry Schein by 57.1% in the second quarter. Fuller & Thaler Asset Management Inc. now owns 2,200 shares of the company’s stock valued at $160,000 after buying an additional 800 shares in the last quarter. Institutional investors own 96.65% of the company’s stock.
A number of analysts have recently weighed in on the company. BidaskClub upgraded Henry Schein from a “hold” rating to a “buy” rating in a research note on Wednesday, August 22nd. Robert W. Baird raised their target price on Henry Schein from $83.00 to $90.00 and gave the company an “outperform” rating in a research note on Tuesday, August 7th. Stifel Nicolaus raised their target price on Henry Schein from $76.00 to $81.00 and gave the company a “hold” rating in a research note on Tuesday, August 7th. Craig Hallum raised their target price on Henry Schein from $83.00 to $96.00 and gave the company a “buy” rating in a research note on Tuesday, August 7th. Finally, Zacks Investment Research lowered Henry Schein from a “buy” rating to a “hold” rating in a research note on Saturday, July 14th. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $83.83.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Monday, August 6th. The company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.01 by $0.03. The business had revenue of $3.33 billion for the quarter, compared to analysts’ expectations of $3.31 billion. Henry Schein had a return on equity of 20.40% and a net margin of 3.15%. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter last year, the business earned $0.88 earnings per share. As a group, equities analysts predict that Henry Schein, Inc. will post 4.12 earnings per share for the current fiscal year.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Read More: Understanding the different types of bonds
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.